Septerna, IncFOSTER CITY, CA, United States
Disclosure information not submitted.
ORF16-05 - Characterization of SEP-479, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Saturday, June 13, 20262:15 PM - 2:30 PM CT